EUVIMEDEUVIMED entdecken
Open Access

Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients

Jin-Rong He, Dan Li, Qun-Xian Zhang, Tao Liu, Yu Ding, Chuang-Yan Wu, Shan-Shan Chen, Jiu-Ling Chen

Aging · 2023

DOI: 10.18632/aging.205239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Jin-Rong He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and T…. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCarcinomaHumansFemaleCD8-Positive T-LymphocytesPhosphatidylinositol 3-KinasesPrognosisBiomarkers, TumorTumor MicroenvironmentNK Cell Lectin-Like Receptor Subfamily B

Stichwörter der Autor:innen

BRCAKLRB1biomarkerimmune microenvironmentprognosis

Substanzen

Phosphatidylinositol 3-KinasesBiomarkers, TumorKLRB1 protein, humanNK Cell Lectin-Like Receptor Subfamily B

Autor:innen und Institutionen

  • Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei, China.
  • Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan 442012, Hubei, China.
  • Department of Cardiothoracic Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan 442012, Hubei, China.
  • Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, China.

Zitieren

APA

He, J. R., Li, D., Zhang, Q. X., Liu, T., Ding, Y., Wu, C. Y., Chen, S. S., & Chen, J. L. (2023). Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients. Aging. https://doi.org/10.18632/aging.205239

Vancouver

He JR, Li D, Zhang QX, Liu T, Ding Y, Wu CY, et al. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients. Aging. 2023. doi:10.18632/aging.205239

BibTeX
@article{He2023,
  author = {He, Jin-Rong and Li, Dan and Zhang, Qun-Xian and Liu, Tao and Ding, Yu and Wu, Chuang-Yan and Chen, Shan-Shan and Chen, Jiu-Ling},
  title = {Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients},
  journal = {Aging},
  year = {2023},
  doi = {10.18632/aging.205239}
}
Kostenlos starten →